How much will I get from the Similasan eye drop settlement?

The base payout is $2.50 per eligible product. Consumers who filed without proof of purchase can receive up to $10 per household (4 products maximum). Those with proof of purchase can receive $2.50 for every product purchased with no cap. Final amounts may be adjusted on a pro rata basis depending on the total number of valid claims filed. With nearly 100,000 claims submitted, pro rata adjustments are possible in either direction.

Was proof of purchase required for the Similasan settlement?

No. Proof of purchase was not required. Consumers could file a claim without receipts for up to 4 products at $2.50 each, for a maximum of $10 per household. Those with proof of purchase such as receipts, frequent shopper records, or packaging could claim $2.50 for every product purchased with no cap.

Can I still file a claim for the Similasan eye drop settlement?

No. The claim deadline was October 15, 2025 and has passed. The settlement received final approval on July 17, 2025 and payments are now being distributed to those who filed timely claims. No new claims are being accepted.

How many people filed claims in the Similasan settlement?

According to court records from the final approval hearing on July 17, 2025, nearly 100,000 claim forms were filed in the Similasan eye drop settlement. The total number of claims affects whether payments will be adjusted up or down on a pro rata basis from the $3.575 million settlement fund.

What payment methods are available for the Similasan settlement?

Settlement payments are being distributed via MasterCard virtual prepaid card, Venmo, direct deposit (ACH), Zelle, or paper check, depending on the payment method each claimant selected when filing their claim form. Electronic payment methods typically arrive faster than paper checks.

Will I get a pro rata increase or decrease on my Similasan settlement payment?

Possibly. The settlement agreement provides for pro rata adjustments in both directions. If the total amount needed to pay all valid claims is less than the available fund after fees and costs, each payment will be increased proportionally. If valid claims exceed the fund, payments will be decreased proportionally. With nearly 100,000 claims filed against a $3.575 million fund, the direction of the adjustment depends on the final claims processing results.

$3.575M Similasan Eye Drop Settlement Payments Going Out

Q: Is the Similasan eye drop settlement payment legitimate?

Yes. The Similasan eye drop settlement received final approval from a federal judge on July 17, 2025. Payments are being distributed by the court-appointed settlement administrator via Zelle, Venmo, direct deposit, MasterCard virtual prepaid card, or paper check. If you filed a claim before the October 15, 2025 deadline and received a payment, it is a legitimate settlement disbursement.

Q: When are Similasan settlement payments being sent?

The settlement received final approval on July 17, 2025, and the claim deadline passed on October 15, 2025. Payments are being processed and distributed in early 2026, typically 60 to 90 days after final approval and claims processing is complete. Payment timing depends on the method selected: electronic payments via Zelle, Venmo, and direct deposit arrive faster than paper checks.

Q: What products are covered by the Similasan eye drop settlement?

The settlement covers 16 homeopathic eye products: Similasan Dry Eye Relief, Complete Eye Relief, Allergy Eye Relief, Kids Allergy Eye Relief, Red Eye Relief, Pink Eye Relief, Kids Pink Eye Relief, Aging Eye Relief, Computer Eye Relief, Stye Eye Relief, Pink Eye Nighttime Gel, Dry Eye Nighttime Gel, CVS Pink Eye Drops, Walgreens Stye Eye Drops, Walgreens Pink Eye Drops, and Walgreens Allergy Eye Drops.

Q: What was the Similasan eye drop lawsuit about?

The lawsuit alleged that Similasan deceptively labeled and advertised its eye drops as homeopathic without proper FDA approval, failed to follow Current Good Manufacturing Practices, misleadingly marketed the products as sterile, and failed to disclose the risk of silver sulfate — an ingredient that can decrease night vision and cause irreversible eye and skin discoloration. Similasan denied all allegations.

Q: Are CVS and Walgreens eye drops included in the Similasan settlement?

Yes. The settlement covers private-label eye drops sold at CVS and Walgreens that were manufactured with ingredients supplied by Similasan. Specifically, CVS Pink Eye Drops, Walgreens Stye Eye Drops, Walgreens Pink Eye Drops, and Walgreens Allergy Eye Drops are all covered products. These store-brand drops were made with substantially similar ingredients to the Similasan-branded products.

Q: What is the silver sulfate risk in Similasan eye drops?

The lawsuit alleged that Similasan failed to disclose that its eye drops contained silver sulfate, an ingredient the FDA does not recognize as safe or effective for over-the-counter ophthalmic use. According to the complaint, silver sulfate can decrease night vision and cause irreversible eye and skin discoloration with prolonged use. Similasan denied these allegations.

By Steve Levine

Similasan Eye Drop Settlement Payments 2026 - $3.575 Million Homeopathic Eye Drop Class Action Settlement - Plowden v Similasan Corp - CVS Walgreens Eye Drops

Published: February 25, 2026 — Updated: February 25, 2026

Settlement Amount: $3,575,000

Status: Payments Going Out (2026)

No Proof of Purchase Required (Up to $10 Per Household)

Payment Methods: Zelle, Venmo, Direct Deposit, Prepaid Card, or Check

The $3.575 million Similasan eye drop class action settlement is paying out. Consumers who filed claims for Similasan, CVS, and Walgreens homeopathic eye drops are now receiving settlement payments via Zelle, Venmo, direct deposit, MasterCard virtual prepaid card, or paper check. The settlement received final court approval on July 17, 2025, and payments are being distributed after the October 15, 2025 claim deadline passed and claims processing was completed.

The lawsuit alleged that Similasan — a Swiss company that markets homeopathic health products in the United States — deceptively labeled and advertised its eye drops as “homeopathic” without proper FDA approval, misleadingly marketed the products as “sterile,” and failed to warn consumers about the risk of silver sulfate, an ingredient that can cause irreversible eye and skin discoloration. The settlement covered 16 different eye drop products sold under the Similasan, CVS, and Walgreens brand names.

No proof of purchase was required to file a claim. Consumers without receipts could claim up to $10 per household ($2.50 per product for up to 4 products). Those with proof of purchase could claim $2.50 for every product they bought with no cap. Nearly 100,000 claim forms were submitted before the deadline.

Here is the full breakdown of what happened, what your payment means, and how the settlement fund is being distributed.

See full settlement details on OpenClassActions.com

Is the Similasan Eye Drop Settlement Payment Legitimate?

Yes. The Similasan eye drop settlement payment is real and legitimate. The $3.575 million settlement in Plowden et al. v. Similasan Corp. received final approval from a federal judge in the U.S. District Court for the District of Colorado on July 17, 2025. If you filed a claim before the October 15, 2025 deadline and received a payment via Zelle, Venmo, direct deposit, MasterCard prepaid card, or check, it is a court-authorized settlement disbursement.

The settlement administrator is distributing payments from the $3.575 million fund. Payments are being sent to the email address, phone number, or mailing address that claimants provided on their claim forms. If you filed a claim months ago and are now receiving an unexpected electronic payment, it is most likely this settlement.

How Much Will You Get from the Similasan Settlement?

The Similasan eye drop settlement pays $2.50 per eligible product. How much you receive depends on whether you filed with or without proof of purchase and how many products you claimed:

Similasan Settlement Payment Amounts

● Without Proof of Purchase: $2.50 per product, up to 4 products = $10.00 maximum per household

● With Proof of Purchase: $2.50 per product, no cap — claim for every product purchased with valid receipts, frequent shopper records, or packaging

● Claims limited to one per household

● Pro rata adjustment possible: If valid claims exceed the available fund after fees and costs, payments will be reduced proportionally. If fewer claims were filed than expected, payments could be increased.

Nearly 100,000 claim forms were filed in this settlement according to court records from the final approval hearing. The direction and size of any pro rata adjustment depends on the total value of all approved claims relative to the net settlement fund after attorney fees, administration costs, and service awards are deducted.

$3.575 Million Settlement Fund Breakdown

● Attorney Fees: Up to ~$1.19 million (one-third of the fund)

● Administration Costs: Deducted from the fund for claims processing and payment distribution

● Service Awards: Up to $2,500 each for three named plaintiffs David Plowden, Mario Ortega, and Kamille Faye Vinluan-Jularbal ($7,500 total)

● Net Fund for Claimants: Remaining balance after all deductions

● Residual Funds: Any money remaining after all payments are distributed will be donated to The Public Justice Foundation

If every one of the approximately 100,000 claimants filed without proof of purchase and claimed the maximum $10, the total payout would be $1 million — well within the estimated net fund. This means pro rata increases are possible for this settlement, meaning you could receive more than $10 rather than less. However, claimants with proof of purchase could have claimed unlimited products, so the final calculation depends on the total value of all claims combined.

What Products Are Covered by the Similasan Eye Drop Settlement?

The settlement covers 16 homeopathic eye products manufactured, distributed, or sold by Similasan Corporation, including private-label versions sold at CVS and Walgreens. The CVS and Walgreens products were made with ingredients supplied by Similasan and are substantially similar to the Similasan-branded products.

All 16 Covered Products

● Similasan Dry Eye Relief
● Similasan Complete Eye Relief
● Similasan Allergy Eye Relief
● Similasan Kids Allergy Eye Relief
● Similasan Red Eye Relief
● Similasan Pink Eye Relief
● Similasan Kids Pink Eye Relief
● Similasan Aging Eye Relief
● Similasan Computer Eye Relief
● Similasan Stye Eye Relief
● Similasan Pink Eye Nighttime Gel
● Similasan Dry Eye Nighttime Gel
● CVS Pink Eye Drops
● Walgreens Stye Eye Drops
● Walgreens Pink Eye Drops
● Walgreens Allergy Eye Drops

To qualify, you must have purchased one or more of these products in the United States for personal use (not for resale) between September 11, 2017 and February 20, 2025. The class period covers approximately seven and a half years of purchases. Many consumers bought these products regularly at pharmacy chains, grocery stores, and online retailers, often as an alternative to conventional medicated eye drops.

What Was the Similasan Eye Drop Lawsuit About?

The lawsuit, officially titled Plowden et al. v. Similasan Corporation, was originally filed in September 2023 in the U.S. District Court for the District of Colorado. Three named plaintiffs — David Plowden, Mario Ortega, and Kamille Faye Vinluan-Jularbal — brought the case on behalf of all U.S. consumers who purchased the covered products.

The complaint alleged four main violations:

First, that Similasan deceptively labeled and advertised its eye drops as “homeopathic” when the products had not secured the appropriate approvals from the FDA. The plaintiffs argued that consumers understood “homeopathic” to mean the products met certain recognized standards, when in fact they did not have FDA approval recognizing them as safe and effective.

Second, that the eye drops were not manufactured according to Current Good Manufacturing Practices (cGMP), the FDA’s quality standards for pharmaceutical production. This meant the products could not reliably ensure consistent quality, purity, or potency.

Third, that Similasan misleadingly marketed the products as “sterile” without adequate clinical validation. For eye drops applied directly to a sensitive organ, sterility claims carry significant medical weight, and the lawsuit alleged these claims were unsubstantiated.

Fourth, that the products contained silver sulfate — an ingredient the FDA does not consider safe or effective for over-the-counter ophthalmic use — without disclosing the associated risks. According to the complaint, silver sulfate can decrease night vision and cause irreversible discoloration of the eyes and skin with prolonged use. This risk was never communicated to consumers on the product labeling.

Similasan Corporation denied all allegations throughout the proceedings and entered the settlement without any admission of wrongdoing. The company asserted that its products were clearly labeled as not reviewed by the FDA. Despite the denial, Similasan agreed to pay $3.575 million to resolve the case and avoid the expense and uncertainty of continued litigation.

When Are Similasan Settlement Payments Being Sent?

The Similasan eye drop settlement received final approval on July 17, 2025. The claim deadline passed on October 15, 2025. Settlement payments are being processed and distributed in early 2026.

Complete Settlement Timeline

● September 16, 2023: Original lawsuit filed in U.S. District Court for the District of Colorado

● November 6, 2024: Settlement agreement filed with the court

● February 20, 2025: Preliminary approval granted (end of class period)

● May 16, 2025: Settlement made public

● May 27, 2025: Deadline to opt out or file objections

● July 17, 2025: Final approval hearing — final approval granted; nearly 100,000 claims filed

● October 15, 2025: Claim form deadline (passed)

● Early 2026: Settlement payments being distributed

Payments typically arrive 60 to 90 days after final approval and completion of claims processing. Electronic payments via Zelle, Venmo, and direct deposit are generally distributed faster than paper checks. If you selected a MasterCard virtual prepaid card, the card details will be sent to the email address on your claim form.

No Proof of Purchase Was Required for the Similasan Settlement

The Similasan eye drop settlement was a no proof required class action settlement for claims up to $10 per household. Consumers who could not produce receipts or purchase records could still file and receive $2.50 for each of up to 4 covered products, simply by affirming their purchases under penalty of perjury.

This low barrier to entry made the settlement accessible to the vast majority of consumers who had purchased Similasan, CVS, or Walgreens homeopathic eye drops over the seven-and-a-half-year class period but had long since discarded any proof. Eye drops are a low-cost, frequent-purchase product, and virtually no one keeps receipts for them.

Consumers who did have proof of purchase — such as store receipts, frequent shopper program records, or original packaging — could claim $2.50 for every product they bought during the class period with no cap. For consumers who purchased these products regularly over many years, the no-cap provision could yield significantly higher payouts.

Valid proof of purchase included store receipts, credit card or bank statements showing the purchase, frequent shopper program records, or product packaging that documented a purchase on or before February 20, 2025.

What Is the Silver Sulfate Risk in Similasan Eye Drops?

One of the most significant allegations in the lawsuit concerned silver sulfate, an ingredient present in certain Similasan eye drop products. The complaint alleged that the FDA does not recognize silver sulfate as safe or effective for over-the-counter ophthalmic use, and that Similasan failed to disclose the associated health risks on product labeling.

According to the lawsuit, prolonged use of products containing silver sulfate can lead to decreased night vision and irreversible discoloration of the eyes and skin — a condition known as argyria when it affects the skin. These are serious side effects for a product marketed as a gentle, natural remedy for common eye conditions like dry eyes, allergies, and pink eye.

Similasan denied these allegations and maintained that its products were safe. The settlement resolved the claims without any admission of wrongdoing. However, many consumers who used these products daily for years were unaware of the potential risks until the lawsuit brought them to light.

How Similasan Settlement Payments Are Being Distributed

The settlement administrator is distributing payments through five different methods, depending on what each claimant selected when filing their claim form:

MasterCard Virtual Prepaid Card: A digital prepaid card number is emailed to you. You can use it for online purchases or add it to a digital wallet. No physical card is mailed.

Venmo: The payment is sent directly to your Venmo account based on the contact information on your claim form. The funds appear in your Venmo balance and can be transferred to your bank.

Direct Deposit (ACH): The payment is deposited directly into the bank account you specified on your claim form. This is typically the fastest method.

Zelle: The payment is sent to the phone number or email address associated with your Zelle account. It appears as a standard Zelle transfer in your banking app.

Paper Check: A physical check is mailed to the address on your claim form. Checks should be deposited promptly to avoid expiration.

Why Did the Similasan Settlement Attract Nearly 100,000 Claims?

The Similasan eye drop settlement attracted a massive volume of claims for several reasons. The covered products were widely available at major pharmacy chains including CVS and Walgreens, meaning millions of American consumers had purchased them over the seven-and-a-half-year class period. Similasan markets itself as a natural alternative to conventional eye drops, appealing to health-conscious consumers who specifically seek homeopathic products — making the deceptive labeling allegations particularly impactful for this audience.

The no-proof-required filing option eliminated the biggest barrier to participation. Most people do not save receipts for $8 to $12 eye drop purchases, so requiring proof would have dramatically reduced the claim rate. By allowing claims under penalty of perjury, the settlement ensured broad participation.

Additionally, word of the settlement spread quickly through social media and class action communities where consumers share information about settlements with easy filing processes and no proof requirements. The growing community of class action enthusiasts who systematically file claims in every available settlement likely contributed significantly to the nearly 100,000 submissions.

Attorneys and Parties in the Similasan Settlement

Class Counsel representing the plaintiff class:

• Melissa S. Weiner of Pearson Warshaw LLP
• Rachel Soffin and Nick Suciu of Milberg Coleman Bryson Phillips Grossman PLLC
• Jonas Jacobson of Dovel & Luner LLP
• William H. Anderson of Handley Farah & Anderson PLLC

Defense Counsel: John C. Dougherty, Arameh O’Boyle, and Katherine Galle of Dentons US LLP

Named Plaintiffs: David Plowden, Mario Ortega, and Kamille Faye Vinluan-Jularbal (service awards of up to $2,500 each)

Defendant: Similasan Corporation

Settlement Administrator: Homeopathic Eye Drop Settlement Claims Administrator, 1650 Arch Street, Suite 2210, Philadelphia, PA 19103

What Should You Do Now?

If you received a Similasan eye drop settlement payment via Zelle, Venmo, direct deposit, MasterCard prepaid card, or check, accept or use it. No further action is required. The payment is yours.

If you received a paper check, deposit it promptly. Do not let it expire. If you received a MasterCard virtual prepaid card via email, check your inbox and spam folder for an email containing the card details.

Keep records of all payments received for tax purposes. Class action payouts may be taxable, and you may receive a 1099 form if your total payments exceed IRS reporting thresholds. Consult a tax advisor if you have questions.

If you did not file a claim before the October 15, 2025 deadline, you are not eligible to receive a payment from this settlement. The claims period is closed. However, you can sign up for free settlement alerts from OpenClassActions.com to be notified of future class action settlements you may qualify for, including other no-proof-required settlements paying out in 2026.

Similasan Eye Drop Settlement — Frequently Asked Questions

Is the Similasan eye drop settlement payment legitimate?
Yes. The settlement received final approval on July 17, 2025 from a federal judge in Colorado. Payments are being distributed by the court-appointed settlement administrator. If you filed a claim and received a payment, it is real.

How much will I get from the Similasan settlement?
$2.50 per eligible product. Without proof of purchase: up to $10 per household (4 products max). With proof of purchase: $2.50 per product with no cap. Final amounts may be adjusted pro rata depending on total claims.

When are Similasan settlement payments being sent?
Payments are being processed and distributed in early 2026. The settlement received final approval in July 2025 and claims closed in October 2025. Electronic payments arrive faster than paper checks.

Can I still file a claim?
No. The claim deadline was October 15, 2025 and has passed. No new claims are being accepted.

Was proof of purchase required?
No. Consumers could file without receipts for up to 4 products ($10 max per household). Those with proof of purchase could claim every product with no cap.

What products are covered?
16 products: Similasan Dry Eye Relief, Complete Eye Relief, Allergy Eye Relief, Kids Allergy Eye Relief, Red Eye Relief, Pink Eye Relief, Kids Pink Eye Relief, Aging Eye Relief, Computer Eye Relief, Stye Eye Relief, Pink Eye Nighttime Gel, Dry Eye Nighttime Gel, CVS Pink Eye Drops, Walgreens Stye Eye Drops, Walgreens Pink Eye Drops, and Walgreens Allergy Eye Drops.

Are CVS and Walgreens eye drops included?
Yes. CVS Pink Eye Drops, Walgreens Stye Eye Drops, Walgreens Pink Eye Drops, and Walgreens Allergy Eye Drops are all covered. These private-label products were manufactured with ingredients supplied by Similasan.

What is the silver sulfate risk?
The lawsuit alleged Similasan failed to disclose that its eye drops contained silver sulfate, which the FDA does not recognize as safe or effective for OTC eye products. The complaint claimed silver sulfate can decrease night vision and cause irreversible eye and skin discoloration. Similasan denied these allegations.

How many claims were filed?
Nearly 100,000 claim forms were submitted according to court records from the July 17, 2025 final approval hearing.

What payment methods are available?
MasterCard virtual prepaid card, Venmo, direct deposit (ACH), Zelle, or paper check — depending on what you selected when filing.

Will payments be increased or decreased?
Possibly. The settlement allows pro rata adjustments in both directions. If total claims are less than the available fund, payments increase. If claims exceed the fund, payments decrease. The direction depends on final processing results.

Where do leftover funds go?
Any residual funds remaining after all payments are distributed will be donated to The Public Justice Foundation as a cy pres distribution.

Are settlement payments taxable?
Possibly. Class action payouts may be taxable if they exceed IRS reporting thresholds. Consult a tax advisor and keep records of all payments received.

How Do I Find Class Action Settlements?

Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:

Case Details

Case: Plowden et al. v. Similasan Corporation, Case No. 1:23-cv-02511-DDD-STV
Court: U.S. District Court, District of Colorado
Settlement Amount: $3,575,000
Claim Deadline: October 15, 2025 (passed)
Final Approval: July 17, 2025
Payments: Being distributed (early 2026)
Payment Methods: MasterCard virtual prepaid card, Venmo, direct deposit, Zelle, or paper check
Official Settlement Website: Here

Sources

• OpenClassActions.com — Similasan Eye Drop Class Action Settlement
• Settlement Agreement, Case Doc. (November 6, 2024)
• Final Approval Order, Case Doc. (July 17, 2025)
• Official Settlement Website — HomeopathicEyeDropSettlement.com

See full settlement details and claim information on OpenClassActions.com »

For more open class actions keep scrolling below.

Open Class Action Lawsuit and Class Action Settlement

Bayer RoundUp Bug Spray Lawsuits

Status: Open to Claims

Submit Claim

Video Game Addiction Lawsuit

Deadline: Pending

Submit Claim

DraftKings & FanDuel Addiction Lawsuits

Status: Open

Submit Claim

Children playing Roblox and using Discord?

Pre-Qualify Here

Submit Claim

File a rebate form to get a coupon, refund, rebate, or payment from this class action settlement

$7.25 Billion RoundUp Bug Spray Settlement

Deadline: Pending

Learn More

$4.17M RevitaLash Conditioner Settlement

Deadline: April 20, 2026

Submit Claim

$87.5M Beef Prices Settlement

Deadline: June 30, 2026

Submit Claim

Dollar General Bait & Switch Settlement

Deadline: April 13, 2026

Submit Claim

Belkin Power Bank Settlement

Deadline: March 30, 2026

Submit Claim

Michael Kors Outlet Class Action Settlement

Deadline: March 6, 2026

Submit Claim

$4.85M Bayer Antifungal Spray Settlement

Deadline: March 11, 2026

Submit Claim

Balance of Nature $9.95M Class Action

Deadline: March 11, 2026

Submit Claim

Similasan Eye Drop Settlement Summary
Status	Payments Going Out (2026)
Settlement Amount	$3,575,000
Payout Per Product	$2.50 (pro rata adjustable)
Max Without Proof	$10.00 per household
Max With Proof	No cap
Claims Filed	~100,000
Products Covered	16 (Similasan, CVS, Walgreens)
Payment Methods	Prepaid Card, Venmo, Direct Deposit, Zelle, Check
Claim Deadline	October 15, 2025 (passed)
Final Approval	July 17, 2025
Case	Plowden v. Similasan Corp., No. 1:23-cv-02511
Court	D. Colo.